GGHC
BNTX icon

Gilder Gagnon Howe & Co’s BioNTech BNTX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,287
Closed -$3.07M – 254
2025
Q4 		$3.07M Sell
32,287
-136,584
-81% -$13.8M 0.03% 174
2025
Q3 		$16.7M Sell
168,871
-498,764
-75% -$53.3M 0.17% 97
2025
Q2 		$71.1M Buy
667,635
+18,351
+3% +$1.85M 0.75% 43
2025
Q1 		$59.1M Buy
649,284
+367,872
+131% +$41.2M 0.77% 43
2024
Q4 		$32.1M Buy
281,412
+5,581
+2% +$637K 0.35% 69
2024
Q3 		$32.8M Sell
275,831
-1,467
-0.5% -$135K 0.39% 64
2024
Q2 		$22.3M Buy
277,298
+2,550
+0.9% +$233K 0.28% 84
2024
Q1 		$25.3M Sell
274,748
-84,960
-24% -$8.15M 0.32% 73
2023
Q4 		$38M Sell
359,708
-46,685
-11% -$4.7M 0.52% 51
2023
Q3 		$44.2M Sell
406,393
-55,885
-12% -$6.18M 0.67% 47
2023
Q2 		$49.9M Buy
462,278
+6,422
+1% +$722K 0.68% 41
2023
Q1 		$56.8M Sell
455,856
-2,564
-0.6% -$352K 0.94% 33
2022
Q4 		$68.9M Buy
458,420
+40,478
+10% +$6.23M 1.28% 21
2022
Q3 		$56.4M Buy
417,942
+145,658
+53% +$22.3M 0.98% 26
2022
Q2 		$40.6M Sell
272,284
-27,800
-9% -$4.25M 0.72% 39
2022
Q1 		$51.2M Sell
300,084
-56,990
-16% -$9.58M 0.47% 61
2021
Q4 		$92.1M Buy
357,074
+305,931
+598% +$83.8M 0.52% 63
2021
Q3 		$14M Buy
51,143
+14,178
+38% +$4.51M 0.07% 178
2021
Q2 		$8.28M Buy
+36,965
New +$6.97M 0.04% 226

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gilder Gagnon Howe & Co's BNTX Position: Q1 2026 in Review

Gilder Gagnon Howe & Co sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 32,287 shares — an estimated $3.07M sold.

Gilder Gagnon Howe & Co first reported a position in BNTX in Q2 2021 and held it in 19 quarters. The position peaked at $92.1M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Gilder Gagnon Howe & Co reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 32,287 BioNTech shares in Q1 2026, an estimated $3.07M.
  • Gilder Gagnon Howe & Co first reported a position in BioNTech in Q2 2021 and held it in 19 quarters.
  • Gilder Gagnon Howe & Co's BioNTech position peaked at $92.1M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2026, filed 15 May 2026.